Open navigation
Search
Search
Christoph Lächler
Partner

Dr. Christoph Lächler

Rechtsanwalt

Languages
  • German
  • English
  • French
Social media

Christoph Lächler specialises in private equity and M&A transactions, advising German and international investors and companies on cross-border company acquisitions and sales, add-on transactions, joint ventures and other cooperation agreements. His clients include strategic investors as well as family equity investors. Christoph also has special expertise in the life Sciences and healthcare sectors with a focus on advising on M&A transactions related to outpatient and inpatient services.

Christoph joined CMS in 2007 and was made partner in 2017. Alongside his legal practice, he has been a lecturer at Steinbeis School of International Business and Entrepreneurship since 2011.

Awards & Recognitions
01
  • Quote
    Listed for Corporate
    Deutschlands beste Anwälte 2025 – Handelsblatt in Kooperation mit Best Lawyers
  • Quote
    Listed for Mergers and Acquisitions
    Deutschlands beste Anwälte 2025 – Handelsblatt in Kooperation mit Best Lawyers
  • Quote
    „Christoph Lächler: Hohes Maß an Engagement und gutes wirtschaftliches Verständnis.“, Mandant
    The Legal 500 Deutschland, 2025
  • Quote
    Listed for Corporate
    Deutschlands beste Anwälte 2024 – Handelsblatt in Kooperation mit Best Lawyers
  • Quote
    Listed for Mergers and Acquisitions
    Deutschlands beste Anwälte 2024 – Handelsblatt in Kooperation mit Best Lawyers
  • Quote
    ‘Very good specialist knowledge combined with a very pragmatic, solution-oriented approach. Respective teams led by Christoph Lächler are deeply anchored in the healthcare sector and have years of experience in this field.’, client
    The Legal 500 EMEA, 2024
  • Quote
    Listed for Corporate
    Deutschlands beste Anwälte 2023 – Handelsblatt in Kooperation mit Best Lawyers
  • Quote
    "Very competent, quick-reacting contact persons, especially Christoph Lächler, who has very sound legal knowledge and uses it optimally.", client
    The Legal 500 EMEA, 2022
  • Quote
    Leading lawyer for mergers & acquisitions
    Kanzleimonitor 2021, 2022
  • Quote
    Leading lawyer for mergers & acquisitions
    Kanzleimonitor 2020, 2021
  • Quote
    "Very competent, quick-reacting contact persons, especially Christoph Lächler, who has very sound legal knowledge and uses it optimally.", client
    The Legal 500 EMEA, 2022

Publications

  • “Getting the Deal Through: Healthcare M&A, Country Report Germany, September 2019, Law Business Research Ltd.” (together with Dr Roland Wiring und Daniel Mahn)
  • Familienverfassung und Family Governance, in: von Rechenberg/Thies/Wiechers (Hrsg.), Handbuch Familienunternehmen und Unternehmerfamilien, Stuttgart 2016
  • Kommentierung zum SE-Konzernrecht, in: Lutter/Hommelhoff/Teichmann (Hrsg.), SE-Kommentar, 2. Aufl., Köln, 2015 (together with Prof. Dr Dr h.c. mult. Peter Hommelhoff)
  • Förder- und Schutzrecht für den SE-Konzern, AG 2014, p. 257 ff. (together with Prof. Dr Dr h.c. mult. Peter Hommelhoff)
  • Das Konzernrecht der Europäischen Gesellschaft (SE): Unter besonderer Berücksichtigung der Mitgliedstaaten Deutschland, Frankreich, England und Polen 2007, Baden-Baden
  • Funktion und Umfang des Regelungsbereichs der SE-Verordnung, NZG 2005, p. 381 ff. (together with K. Oplustil)

Education

  • 2007: Second state examination in law
  • Trainee lawyer at Ellwangen Regional Court including placements in Stuttgart and New York
  • PhD; thesis on the group law of the Societas Europaea (SE) under the supervision of Prof. Dr. Dr. Dres. h.c. Peter Hommelhoff, European Post Graduate Programme at the University of Heidelberg
  • 2003: First state examination in law
  • Law and economics studies at the University of Heidelberg

Insights by Christoph

CMS advises SYNLAB on the sale of synlab slovakia s.r.o. to Unilabs Group

CMS advises SYNLAB on the sale of synlab slovakia s.r.o. to Unilabs Group

11 Feb 2026 2 min read
CMS advises Sunrise Medical on the acquisition of Ergoflix Group

CMS advises Sunrise Medical on the acquisition of Ergoflix Group

23 Jan 2026 2 min read
CMS advises Jamco Corporation on the acquisition of Schüschke Holding GmbH

CMS advises Jamco Corporation on the acquisition of Schüschke Holding GmbH

23 Jan 2026 1 min read
CMS Reception at JP Morgan Healthcare Conference Week 2026

CMS Reception at JP Morgan Healthcare Conference Week 2026

15 Jan 2026
Back to top Back to top
Opens in new window